4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000156
CEO & President sold 15,202 shares at $447.00 ($6,795,294)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kewalramani Reshma · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-20 | Sale : show line 1 in the form 10b5-1 | −15,202 | $447.00 | $6,795,294 | 121,374 | D |
| Open-market sales · 15,202 sh · avg $447.00 · $6,795,294 | ||||||
Loading xslF345X05/wk-form4_1716409296.xml…